Ozanimod
Indication
Treating moderately to severely active ulcerative colitis - NICE TA828
NICE TA828 - Ozanimod for treating moderately to severely active ulcerative colitis
Red
Brand:
Nice TA:
828
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Gastro-intestinal system
Background
1.1 Ozanimod is recommended as an option for treating moderately to severely active ulcerative colitis in adults, only if:
-
conventional treatment cannot be tolerated or is not working well enough and infliximab is not suitable, or
-
biological treatment cannot be tolerated or is not working well enough, and
-
the company provides it according to the commercial arrangement.